Topical antifungal vs placebo/no treatment
Adverse effects ‐ epistaxis · chronic rhinosinusitis
Topical antifungal showed no clear difference in adverse effects ‐ epistaxis compared with placebo/no treatment (low certainty).
1 finding from 1 review
- Topical and systemic antifungal therapy for chronic rhinosinusitis 2018 · Cochrane Headline outcomes onlyRR 0.97 [0.14, 6.63]Studies not reportedLow